Mixed Messages for RNAi.
- Published in:
- 2011
- By:
- Publication type:
- Opinion
Works matching DE "QUARK Pharmaceuticals Inc."
Results: 2
1
2
Pfizer and Quark Pharmaceuticals' siRNA treatment may stabilize vision in wet age-related macular degeneration.
- Published in:
- Expert Review of Ophthalmology, 2009, v. 4, n. 3, p. 219
- Publication type:
- Article